Maedeh Ghorbani's research while affiliated with Islamic Azad University, Shahrekord Branch and other places

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (1)


Genotyping of rs77493513 polymorphism by PCR-RFLP and gel electrophoresis on 1.5% agarose gel. Genotype AA – wells 3 and 4 – results in two bands (217 bp and 357 bp), genotype AC – well 5 – results three bands (574, 357 and 217 bp), genotype CC – wells 1 and 2 – (574 bp). Well M is the 100 bp DNA standard marker
Significant Association of rs77493513 Polymorphism in 3'-UTR of the NRG1 Gene with the Risk of Multiple Sclerosis Disease
  • Article
  • Publisher preview available

April 2022

·

30 Reads

·

2 Citations

Metabolic Brain Disease

Maedeh Ghorbani

·

·

Multiple sclerosis (MS) is a chronic inflammatory and autoimmune disease characterized by demyelination of the central nervous system (CNS). Neuregulin 1 (NRG1) is a signaling protein that plays an important role in a variety of biological processes, including potentiate oligodendrocyte differentiation and myelination in the CNS, immune response regulation, and inflammation. Single nucleotide polymorphism (SNP) rs77493513 is located in the untranslated region of the 3' mRNA (3'-UTR) of the NRG1 gene, which is predicted to be the binding site of several microRNAs and may play an important role in post-transcriptional regulation. Study aimed to investigate the association of SNP rs77493513 in the NRG1 gene with the risk of MS disease. In this study, genomic DNA was extracted from whole blood samples of 182 patients with relapsing-remitting multiple sclerosis (RRMS) and 198 controls. Different genotypes of rs77493513 polymorphism were determined using RFLP-PCR technique. Statistical analysis was performed using SPSS 21.0 software and by t, χ2 and logistic regression tests. Our data showed that genotypes AC (OR=3.63, CI= 1.93-6.81, p<0.001) and CC (OR=7.90, CI= 4.13-15.11, p<0.001) significantly increased the risk of MS disease and C allele is risk allele. Also, AC (OR=0.16, CI= 0.04-0.63, p= 0.009) and CC (OR=0.14, CI= 0.03-0.53, p=0.04) genotypes significantly decrease the age of onset of the disease. The results show that allele C of rs77493513 polymorphism in the NRG1 gene can be a risk factor for MS.

View access options
Share

Citations (1)


... -15,31-33 The 5 0 and 3 0 untranslated regions (UTR) sequences flanked in the coding regions can be transcribed into mRNAs, but not translated into proteins. The SNP sites located in the UTR regions can induce disordered processes of post-transcription by altering the stability or secondary structure of mRNA and interactions with miRNAs.[34][35][36][37][38] SNP mutations occur not only in the binding region of miRNA but also in the seed region of miRNA itself. ...

Reference:

Strategies for activity analysis of single nucleotide polymorphisms associated with human diseases
Significant Association of rs77493513 Polymorphism in 3'-UTR of the NRG1 Gene with the Risk of Multiple Sclerosis Disease

Metabolic Brain Disease